Brigette Boast,Shubham Goel,Luis I González-Granado,Julie Niemela,Jennifer Stoddard,Emily S J Edwards,Sandali Seneviratne,Dominik Spensberger,Juan F Quesada-Espinosa,Luis M Allende,John McDonnell,Alexandria Haseley,Harry Lesmana,Magdalena A Walkiewicz,Emad Muhammad,Julian J Bosco,Thomas A Fleisher,Shai Cohen,Steven M Holland,Menno C van Zelm,Anselm Enders,Hye Sun Kuehn,Sergio D Rosenzweig

Abstract:Background: TCF3 is a transcription factor contributing to early lymphocyte differentiation. Germline monoallelic dominant negative and biallelic loss-of-function (LOF) null TCF3 mutations cause a fully penetrant severe immunodeficiency. We identified 8 individuals from 7 unrelated families with monoallelic LOF TCF3 variants presenting with immunodeficiency with incomplete clinical penetrance. Objective: We sought to define TCF3 haploinsufficiency (HI) biology and its association with immunodeficiency. Methods: Patient clinical data and blood samples were analyzed. Flow cytometry, Western blot analysis, plasmablast differentiation, immunoglobulin secretion, and transcriptional activity studies were conducted on individuals carrying TCF3 variants. Mice with a heterozygous Tcf3 deletion were analyzed for lymphocyte development and phenotyping. Results: Individuals carrying monoallelic LOF TCF3 variants showed B-cell defects (eg, reduced total, class-switched memory, and/or plasmablasts) and reduced serum immunoglobulin levels; most but not all presented with recurrent but nonsevere infections. These TCF3 LOF variants were either not transcribed or translated, resulting in reduced wild-type TCF3 protein expression, strongly suggesting HI pathophysiology for the disease. Targeted RNA sequencing analysis of T-cell blasts from TCF3-null, dominant negative, or HI individuals clustered away from healthy donors, implying that 2 WT copies of TCF3 are needed to sustain a tightly regulated TCF3 gene-dosage effect. Murine TCF3 HI resulted in a reduction of circulating B cells but overall normal humoral immune responses. Conclusion: Monoallelic LOF TCF3 mutations cause a gene-dosage-dependent reduction in wild-type protein expression, B-cell defects, and a dysregulated transcriptome, resulting in immunodeficiency. Tcf3+/- mice partially recapitulate the human phenotype, underscoring the differences between TCF3 in humans and mice.

A human ITPR3 variant causes a dominant negative attenuation of calcium responses with immunodeficiency and growth delay confirmed in a mouse model

A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease

Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease

[Immunophenotyping by spectral cytometry reveals a profile of lymphopenia associated with deregulation with an increase in effector memory lymphocytes in a patient with a mutation in the ITPR3 gene]

ITPR3‐associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease

A Gain-of-function Mutation in the Gating Domain of ITPR1 Impairs Motor Movement and Increases Thermal and Mechanical Sensitivity

IP3 receptor depletion in a spontaneous canine model of Charcot-Marie-Tooth disease 1J with amelogenesis imperfecta

INPP4A-related genetic and phenotypic spectrum and functional relevance of subcellular targeting of INPP4A isoforms

Itpr1 Mutation Contributes To Hemifacial Microsomia Spectrum

ITPR1 variant-induced autosomal dominant hereditary spastic paraplegia in a Chinese family

Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function

ITPR1: The missing gene in miosis–ataxia syndrome?

Novel Disease-Associated Missense Single-Nucleotide Polymorphisms Variants Predication by Algorithms Tools and Molecular Dynamics Simulation of Human TCIRG1 Gene Causing Congenital Neutropenia and Osteopetrosis

Inositol 1,4,5-Trisphosphate Receptor Mutations Associated with Human Disease: Insights into Receptor Function and Dysfunction

TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

Tissue nonspecific alkaline phosphatase deficiency impairs Purkinje cell development and survival in a mouse model of infantile hypophosphatasia

Variable Syndromic Immunodeficiency in Patients with Biallelic PRIM1 Mutations

Developmental epileptic encephalopathy with hypomyelination and brain atrophy associated with PTPN23 variants affecting the assembly of UsnRNPs

Identification of a Novel Pathogenic TBCK Variant in a Chinese Patient with Infantile Hypotonia with Psychomotor Retardation and Characteristic Facies Type 3 (IHPRF3): a Case Report.

Human iPSC-Derived Neuronal Cells From CTBP1-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene Networks

Heterozygous Splice Mutation in PIK3R1 Causes Human Immunodeficiency with Lymphoproliferation Due to Dominant Activation of PI3K.